Ledger.Open graph →
SEC Form D · filed December 1, 2023

ELIXIRGEN THERAPEUTICS, INC

Offering
$7.0M
Sold
$7.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BALTIMORE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Thomas K. White · Baltimore, MDDirectorAkihiro C. Ko · Baltimore, MDExec · DirectorHiroaki C. Kobayashi · Baltimore, MDDirectorShauna K. Callahan · Baltimore, MDDirectorMinoru S. Ko · Baltimore, MDDirectorJeffrey K. Cleland · Baltimore, MDDirectorOla Soderquist · Needham, MAExec · DirectorTyson Hunt · Columbia, MODirectorJudson Ball · Columbia, MODirectorAndrew Sharp · Columbia, MODirectorEdward Raha · Ponte Vedra Beach, FLDirectorNatalia Pintus · Cleveland, OHExec · DirectorRiley Chaney · Fresno, CADirectorHelena Foulkes · NEW YORK, NYDirectorJack Sarno · NEW YORK, NYDirectorDamien Hooper-Campbell · NEW YORK, NYDirectorJeffrey K. Cleland · Baltimore, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗